AgomAb Therapeutics N.V. American Depositary Shares
NASDAQ:AGMBBiotechnology
+$0.25 today
- Market cap
- $286.62M
- Beta
- 2.62
- P/E (TTM)
- -7.1
- EPS (TTM)
- -$1.28
Volume 0.13M
Average 0.14M
AGMB Other Current Liabilities
Short-term obligations not reported separately, such as accrued expenses.
AgomAb Therapeutics N.V. American Depositary SharesNASDAQ: AGMB
Other Current Liabilities · Q3 FY2025 · quarter ended Sep 2025
Other current liabilities of €0 in Q3 FY2025
Q3 FY2025 other current liabilities was €0.
Context
- Other current liabilities amounted to 0.0% of total assets at the end of Q3 FY2025.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Liabilities history
Currency unavailable · from the balance sheet
No Other Current Liabilities data reported for this period type.
Other Current Liabilities vs competitors
How AGMB compares with its peers on the latest reported figures
- Peers report in different currencies, so other current liabilities is compared through growth and share of total assets rather than absolute size.
- Other current liabilities amounts to 0.0% of total assets for AGMB, versus a peer median of 5.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
ALMSAlumis Inc. Common Stock | Jun 2026 | $51.94M USD | +304.3% | +151.8% | 9.3% |
| Mar 2026 | $26.53M USD | +408.5% | +27.3% | 8.0% | |
| Mar 2026 | $6.06M USD | -39.9% | -8.8% | 3.0% | |
| Mar 2026 | $1.13M USD | -49.7% | — | 1.8% | |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | Sep 2025 | €0 EUR | — | — | 0.0% |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
| Peer median (excluding AGMB) | — | +132.2% | +27.3% | 5.5% | |
Competitors are the stored peer set for AGMB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
AgomAb Therapeutics N.V. American Depositary Shares
NASDAQ:AGMB
Intrinsic Alpha fair value
Locked
Current Price
$5.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.